CCL2 and Alzheimer disease: Additionally, the HF and EF samples significantly reduced the expression levels of TARC (Fig. 7A), MDC (Fig. 7B), IL-6 (Fig. 7C), and MCP-1 (Fig. 7F), indicating their potential to suppress AD.